Author

Susan K. Nolte

Observed names: SUSAN K. NOLTE, SUSAN NOLTE, Sarah Nolte, Susan Nolte

Observed institutions: Oregon Health & Science University, Research to Prevent Blindness, Association for Research in Vision and Ophthalmology

OpenAlex ID: A5000476630

Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion

1995 · John G. Clarkson, Elaine Chuang, et al. · Ophthalmology · 508

Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

2010 · Wei Chen, Dwight Stambolian, et al. · Proceedings of the National Academy of Sciences · 507

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

2015 · Alex S. Willoughby, Gui-shuang Ying, et al. · Ophthalmology · 221

Intravitreal Bevacizumab (avastin) Treatment of Neovascular Age-related Macular Degeneration

2007 · M VAUGHN EMERSON, ANDREAS K. LAUER, et al. · Retina · 170

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

2014 · Michael M. Altaweel, Michael M. Altaweel, et al. · Ophthalmology · 51

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

2018 · Lee M. Jampol, Adam R. Glassman, et al. · Ophthalmology · 43

Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

2021 · Maureen G. Maguire, Danni Liu, et al. · JAMA Ophthalmology · 31

Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials

2022 · Jason Q. Core, Maxwell Pistilli, et al. · Ophthalmology Retina · 22

Intraocular Pressure–Related Events After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion

2021 · Ahmad A. Aref, Ingrid U. Scott, et al. · JAMA Ophthalmology · 14

Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial

2023 · Steven M. Kymes, Neal L. Oden, et al. · JAMA Ophthalmology · 10

Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials

2023 · Katie Xue, Peiying Hua, et al. · Ophthalmology Retina · 8

Optical Coherence Tomography Findings During Pegaptanib Therapy for Neovascular Age-related Macular Degeneration

2007 · GEOFFREY G. EMERSON, CHRISTINA J. FLAXEL, et al. · Retina · 7

Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion

2022 · Ingrid U. Scott, Neal L. Oden, et al. · JAMA Ophthalmology · 6

Results ff Optical Coherence Tomography During Pegaptanib (Macugen) Therapy For Neovascular Age–Related Macular Degeneration

2006 · Geoffrey G. Emerson, Susan K. Nolte, et al. · Investigative Ophthalmology & Visual Science

Works count: 18

Citation count: 2,083

H-index: 13

I10-index: 14